Becton, Dickinson and Company (0R19.L)
USD 201.41
(1.79%)
USD 201.41
(1.79%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 26.98 Billion USD | -2.42% |
| 2022 | 27.65 Billion USD | -8.4% |
| 2021 | 30.18 Billion USD | -0.19% |
| 2020 | 30.24 Billion USD | -1.42% |
| 2019 | 30.68 Billion USD | -6.76% |
| 2018 | 32.91 Billion USD | 32.78% |
| 2017 | 24.78 Billion USD | 38.06% |
| 2016 | 17.95 Billion USD | -7.05% |
| 2015 | 19.31 Billion USD | 161.21% |
| 2014 | 7.39 Billion USD | 4.05% |
| 2013 | 7.1 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 26.94 Billion USD | -0.15% |
| 2024 Q3 | 29.71 Billion USD | 4.23% |
| 2024 Q2 | 28.5 Billion USD | 5.82% |
| 2023 Q1 | 27.65 Billion USD | 0.02% |
| 2023 Q4 | 26.98 Billion USD | -0.36% |
| 2023 FY | 26.98 Billion USD | -2.42% |
| 2023 Q3 | 27.08 Billion USD | -5.66% |
| 2023 Q2 | 28.7 Billion USD | 3.79% |
| 2022 FY | 27.65 Billion USD | -8.4% |
| 2022 Q3 | 27.7 Billion USD | -8.45% |
| 2022 Q4 | 27.65 Billion USD | -0.19% |
| 2022 Q2 | 30.26 Billion USD | 3.63% |
| 2022 Q1 | 29.2 Billion USD | -3.27% |
| 2021 FY | 30.18 Billion USD | -0.19% |
| 2021 Q3 | 30.19 Billion USD | 0.35% |
| 2021 Q1 | 30.08 Billion USD | -0.54% |
| 2021 Q2 | 30.09 Billion USD | 0.03% |
| 2021 Q4 | 30.18 Billion USD | -0.03% |
| 2020 FY | 30.24 Billion USD | -1.42% |
| 2020 Q4 | 30.24 Billion USD | 1.04% |
| 2020 Q2 | 32.56 Billion USD | 5.9% |
| 2020 Q3 | 29.93 Billion USD | -8.07% |
| 2020 Q1 | 30.75 Billion USD | 0.22% |
| 2019 FY | 30.68 Billion USD | -6.76% |
| 2019 Q4 | 30.68 Billion USD | -0.17% |
| 2019 Q2 | 31.28 Billion USD | -0.76% |
| 2019 Q3 | 30.73 Billion USD | -1.77% |
| 2019 Q1 | 31.52 Billion USD | -4.2% |
| 2018 FY | 32.91 Billion USD | 32.78% |
| 2018 Q4 | 32.91 Billion USD | 0.89% |
| 2018 Q3 | 32.62 Billion USD | -2.4% |
| 2018 Q2 | 33.42 Billion USD | -2.04% |
| 2018 Q1 | 34.11 Billion USD | 37.64% |
| 2017 Q1 | 16.73 Billion USD | -6.78% |
| 2017 Q2 | 16.15 Billion USD | -3.45% |
| 2017 Q3 | 24.57 Billion USD | 52.12% |
| 2017 Q4 | 24.78 Billion USD | 0.84% |
| 2017 FY | 24.78 Billion USD | 38.06% |
| 2016 Q1 | 18.82 Billion USD | -2.54% |
| 2016 FY | 17.95 Billion USD | -7.05% |
| 2016 Q4 | 17.95 Billion USD | -0.17% |
| 2016 Q3 | 17.98 Billion USD | -3.16% |
| 2016 Q2 | 18.57 Billion USD | -1.34% |
| 2015 Q2 | 21.13 Billion USD | 57.31% |
| 2015 Q1 | 13.43 Billion USD | 81.7% |
| 2015 Q3 | 19.82 Billion USD | -6.19% |
| 2015 Q4 | 19.31 Billion USD | -2.58% |
| 2015 FY | 19.31 Billion USD | 161.21% |
| 2014 Q1 | 6.95 Billion USD | -2.1% |
| 2014 FY | 7.39 Billion USD | 4.05% |
| 2014 Q2 | 6.93 Billion USD | -0.32% |
| 2014 Q3 | 6.99 Billion USD | 0.88% |
| 2014 Q4 | 7.39 Billion USD | 5.69% |
| 2013 Q2 | 7.04 Billion USD | -1.66% |
| 2013 Q3 | 6.87 Billion USD | -2.42% |
| 2013 Q4 | 7.1 Billion USD | 3.43% |
| 2013 Q1 | 7.15 Billion USD | 0.0% |
| 2013 FY | 7.1 Billion USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -22455.084% |
| Accuray Incorporated | 423.54 Million USD | -6271.018% |
| Align Technology, Inc. | 2.45 Billion USD | -999.867% |
| Elevance Health Inc. | 69.52 Billion USD | 61.187% |
| AxoGen, Inc. | 101.16 Million USD | -26574.048% |
| Boston Scientific Corporation | 15.6 Billion USD | -72.908% |
| CVS Health Corporation | 173.09 Billion USD | 84.411% |
| Cardinal Health, Inc. | 48.33 Billion USD | 44.171% |
| Centene Corporation | 58.68 Billion USD | 54.019% |
| DaVita Inc. | 14.87 Billion USD | -81.391% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 51.073% |
| Hologic, Inc. | 4.02 Billion USD | -570.243% |
| Humana Inc. | 30.74 Billion USD | 12.239% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -1419.887% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -205.435% |
| Masimo Corporation | 1.67 Billion USD | -1509.352% |
| McKesson Corporation | 69.04 Billion USD | 60.917% |
| Patterson Companies, Inc. | 1.89 Billion USD | -1323.958% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -254.866% |
| ResMed Inc. | 2 Billion USD | -1243.59% |
| Henry Schein, Inc. | 5.42 Billion USD | -397.86% |
| Teladoc Health, Inc. | 2.06 Billion USD | -1205.912% |
| Universal Health Services, Inc. | 8.15 Billion USD | -230.891% |
| Veeva Systems Inc. | 1.26 Billion USD | -2031.276% |
| Baxter International Inc. | 19.8 Billion USD | -36.228% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -1220.027% |
| Danaher Corporation | 30.99 Billion USD | 12.949% |
| Stryker Corporation | 21.31 Billion USD | -26.573% |
| Medtronic plc | 39.56 Billion USD | 31.791% |